Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-03-01 @ 12:16 AM
Study NCT ID:
NCT02977312
Status:
COMPLETED
Last Update Posted:
2016-11-30
First Post:
2016-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan
Sponsor:
Hikma Pharmaceuticals LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Myeloid Leukemia, Chronic Phase | View |
Keywords: